EquitAI LogoEquitAI
$167.60
-1.19%
RGEN

RGEN

Repligen Corporation

Healthcare
Loading Chart...
FIT ANALYSIS
Required for personalization
STOCK DNA
Valuation
3/10
Quality
4/10
Growth
6/10
Strength
8/10
Dividend
1/10
Price Trend
Upwards
Momentum
Neutral
Balance Sheet
Healthy
Earnings
Growth
Dividend Yield
0.00%
Market Cap
$9.46B
TALK TO YOUR STOCK
EQUITAI ASSISTANT

Repligen Corporation develops and manufactures highly specialized equipment and consumables used in the production of biological drugs. Its core products include advanced filtration systems, chromatography columns, and proprietary proteins that help pharmaceutical companies manufacture complex medicines efficiently. I have synthesized my analysis of its core fundamentals, live market action, and peer metrics to provide a comprehensive thesis. What specific areas can I detail for you?

AI can make mistakes. Verify important information.
Talk to Your Stockopen live chat
Pro EquitAI Research
Retrieving premium status...